It will move only with positive data. I do expect a runup to maybe .30 or a bit higher but with all that's happened in the last year it'd be silly to expect a huge breakout now.
Also most people (at least who I talk with) who have been following this company closely for the past year are expecting some good news at the end of March.
It would be highly shocking if Ifenprodil showed no (or even minimal) efficacy. For one, it would mean Dr Suarez completely misinterpreted what he saw with his patents and that seems very unlikely to me.